Shanghai RAAS Blood Products (002252.SZ) - EPS (earnings per share)

EPS in 2026 (TTM): A$0.07626

According to Shanghai RAAS Blood Products's latest financial reports the company's current EPS (TTM) is A$0.07019. In 2024 the company made an earnings per share (EPS) of A$0.06342 an increase over its 2023 EPS that were of A$0.05358.

EPS history for Shanghai RAAS Blood Products from 2005 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	A$0.07626
2024	A$0.06342	18.38%
2023	A$0.05358	-5.91%
2022	A$0.05694	36.15%
2021	A$0.04182	-7.39%
2020	A$0.04516	87.44%
2019	A$0.02409	-138.11%
2018	A-$0.06322	-272.5%
2017	A$0.03665	-45.02%
2016	A$0.06666	5.85%
2015	A$0.06298	127.47%
2014	A$0.02769	48.29%
2013	A$0.01867	29.9%
2012	A$0.01437	13.1%
2011	A$0.01271	14.18%
2010	A$0.01113	40.49%
2009	A$0.007922	13.05%
2008	A$0.007008	18.08%
2007	A$0.005935	-37.8%
2006	A$0.009542	2.48%
2005	A$0.009311

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Shanghai RAAS Blood Products (002252.SZ)